Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin

Annals of Thoracic Surgery

Volumn 70, Issue 6, 2000, Pages 1853-1860

  Nguyen, Dao M ^a   Desai, Sudhen ^a   Chen, Aaron ^a   Weiser, Todd S ^a   Schrump, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; BENZOQUINONE DERIVATIVE; GELATINASE B; GELDANAMYCIN; GENE PRODUCT; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN;

ARTICLE; CANCER INHIBITION; CANCER PATIENT; CARCINOGENICITY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; ONCOGENE C ERB; ONCOGENE NEU; PHENOTYPE; PRIORITY JOURNAL;

BENZOQUINONES; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTAMS, MACROCYCLIC; LUNG NEOPLASMS; LYMPHOKINES; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RIFABUTIN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034532066     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01810-5     Document Type: Article

References (25)

1. Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
2. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group
3. Mechanisms of tumour metastasis
4. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
5. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
6. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
7. Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung
8. Heregulin and agnostic anti-p-185c-erbB2 antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185c-erbB2: Increased invasiveness may contribute to poor prognosis
9. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
10. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
11. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines
12. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
13. Depletion of p185/erbB-2, Raf-1, mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity
14. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
15. A rapid in vitro assay for quantitating the invasive potential of tumor cells
16. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection
17. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint
18. Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer
19. Cell adhesion molecules and cancer metastasis
20. Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus
21. Matrix metalloproteinases. Novel targets for directed cancer therapy
22. Modulation of the organ microenvironment for treatment of cancer metastasis
23. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer
24. Plasma pharmacokinetics and tissue distribution of 17-allylaminogeldanamycin (NSC330507), a prodrug for geldanamycin, in CD2F1 mice and Fisher 344 rats
25. Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin